Bone loss in elderly women prevented by ultralow doses of parenteral 17β-estradiol
- 1 July 1997
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 177 (1) , 115-119
- https://doi.org/10.1016/s0002-9378(97)70448-4
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Estrogen Replacement Therapy and Fractures in Older WomenAnnals of Internal Medicine, 1995
- Long-term effects of transdermal and oral hormone replacement therapy on postmenopausal bone lossOsteoporosis International, 1994
- Transvaginal sonography of the internal genital organs in postmenopausal women on low-dose estrogen treatmentUltrasound in Obstetrics & Gynecology, 1994
- Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in post‐menopausal osteoporosisClinical Endocrinology, 1994
- Release of 17-Beta-Oestradiol from a Vaginal Ring in Postmenopausal Women: Pharmacokinetic EvaluationGynecologic and Obstetric Investigation, 1994
- Oestradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophyMaturitas, 1993
- Low-dosage micronized 17ß-estradiol prevents bone loss inpostmenopausal womenAmerican Journal of Obstetrics and Gynecology, 1992
- Hormone Replacement Therapy and the Risk for First Hip FractureAnnals of Internal Medicine, 1990
- Vaginal rings for continuous low-dose release of oestradiol in the treatment of urogenital atrophyMaturitas, 1989
- Pathophysiological Mechanisms of Estrogen Effect on Bone Metabolism. Dose-Response Relationships in Early Postmenopausal Women*Journal of Clinical Endocrinology & Metabolism, 1982